Neurotrophic factors and Parkinson's disease: the emergence of a new player?
- PMID: 17986711
- DOI: 10.1126/stke.4112007pe60
Neurotrophic factors and Parkinson's disease: the emergence of a new player?
Abstract
The administration of neurotrophic factors is a potential approach to the therapy of neurodegenerative disorders such as Parkinson's disease. However, issues relating to compound delivery and potential side effects have limited the clinical application of this treatment strategy. The identification of CDNF and MANF, which constitute a new class of neurotrophic factors active against dopaminergic neurons, may provide new hope for therapeutic approaches to neurodegenerative disorders based on neurotrophic factors or downstream components of their signaling pathways.
Similar articles
-
The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.Exp Neurol. 1993 Nov;124(1):103-18. doi: 10.1006/exnr.1993.1181. Exp Neurol. 1993. PMID: 8282068 Review.
-
Novel CDNF/MANF family of neurotrophic factors.Dev Neurobiol. 2010 Apr;70(5):360-71. doi: 10.1002/dneu.20760. Dev Neurobiol. 2010. PMID: 20186704 Review.
-
Neurotrophic factors for the treatment of Parkinson's disease.Cytokine Growth Factor Rev. 2011 Jun;22(3):157-65. doi: 10.1016/j.cytogfr.2011.05.001. Cytokine Growth Factor Rev. 2011. PMID: 21689963 Review.
-
Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.FEBS Lett. 2015 Dec 21;589(24 Pt A):3739-48. doi: 10.1016/j.febslet.2015.09.031. Epub 2015 Oct 9. FEBS Lett. 2015. PMID: 26450777 Review.
-
[Neurotrophins. II: therapeutic potential].Rev Med Univ Navarra. 1997 Jul-Sep;41(3):180-4. Rev Med Univ Navarra. 1997. PMID: 10420924 Review. Spanish.
Cited by
-
Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson's disease.Neural Regen Res. 2019 Aug;14(8):1438-1444. doi: 10.4103/1673-5374.253527. Neural Regen Res. 2019. PMID: 30964070 Free PMC article.
-
BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.Neuropharmacology. 2009 Apr;56(5):876-85. doi: 10.1016/j.neuropharm.2009.01.015. Epub 2009 Jan 21. Neuropharmacology. 2009. PMID: 19371576 Free PMC article.
-
Total synthesis of (+)-nankakurines A and B and (±)-5-epi-nankakurine A.J Org Chem. 2010 Nov 19;75(22):7519-34. doi: 10.1021/jo101619d. Epub 2010 Oct 19. J Org Chem. 2010. PMID: 20958075 Free PMC article.
-
Enantioselective total syntheses of nankakurines A and B: confirmation of structure and establishment of absolute configuration.J Am Chem Soc. 2008 Aug 27;130(34):11297-9. doi: 10.1021/ja804624u. Epub 2008 Aug 2. J Am Chem Soc. 2008. PMID: 18680252 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous